Health Headline: Could K17 be a key treatment target for pancreatic cancer?
A national team of cancer researchers led by Kenneth Shroyer and Natalia Marchenko at Stony Brook Medicine and Luisa Escobar-Hoyos of Yale School of Medicine investigated the role of Keratin 17 (K17) in the most common form of pancreatic cancer.